The LCRF pilot grant program funds innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research, focused on one or more of the following topics:
- Lung cancer biology
- Prevention and screening for early detection
- Identification of new biomarkers
- Development of more effective and less toxic therapies including but not limited to targeted and immune-therapies
- Genetic and gene-environment interactions
- Interactions and contributions of multiple factors (e.g. smoking, genetics, environment, societal factors) to disparities in lung cancer outcomes
- Mechanisms of sensitivity and resistance to lung cancer therapies
- Bioengineering approaches to understanding and/or treating lung cancer (i.e., theranostics, biomaterials, nanotechnology, controlled-drug release, and gene-therapy)
- Supportive measures for people with lung cancer and their families
These awards provide a maximum of $150,000 in funding over a period of two years to early- and mid-career investigators. For full details, eligibility criteria, and application instructions, please refer to the request for proposals.
Deadline for LOI: April 30, 2022